Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 483

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Subcutaneous or Transvenous Defibrillator Therapy

Open access
Knops, Reinoud E., Olde Nordkamp, Louise R.A., Delnoy, Peter-Paul H.M., Boersma, Lucas V.A., Kuschyk, Jürgen, El-Chami, Mikhael F., Bonnemeier, Hendrik, Behr, Elijah R., Brouwer, Tom F., Kääb, Stefan, Mittal, Suneet, Quast, Anne-Floor B.E., Smeding, Lonneke, van der Stuijt, Willeke, de Weger, Anouk, de Wilde, Koen C., Bijsterveld, Nick R., Richter, Sergio, Brouwer, Marc A., de Groot, Joris R., Kooiman, Kirsten M., Lambiase, Pier D., Neuzil, Petr, Vernooy, Kevin, Alings, Marco, Betts, Tim R., Bracke, Frank A.L.E., Burke, Martin C., de Jong, Jonas S.S.G., Wright, David J., Tijssen, Jan G.P., Wilde, Arthur A.M.·2020·New England Journal of Medicine

Abstract

BACKGROUND: The subcutaneous implantable cardioverter-defibrillator (ICD) was designed to avoid complications related to the transvenous ICD lead by using an entirely extrathoracic placement. Evidence comparing these systems has been based primarily on observational studies. METHODS: We conducted a noninferiority trial in which patients with an indication for an ICD but no indication for pacing were assigned to receive a subcutaneous ICD or transvenous ICD. The primary end point was the composite of device-related complications and inappropriate shocks; the noninferiority margin for the upper boundary of the 95% confidence interval for the hazard ratio (subcutaneous ICD vs. transvenous ICD) was 1.45. A superiority analysis was prespecified if noninferiority was established. Secondary end points included death and appropriate shocks. RESULTS: A total of 849 patients (426 in the subcutaneous ICD group and 423 in the transvenous ICD group) were included in the analyses. At a median follow-up of 49.1 months, a primary end-point event occurred in 68 patients in the subcutaneous ICD group and in 68 patients in the transvenous ICD group (48-month Kaplan-Meier estimated cumulative incidence, 15.1% and 15.7%, respectively; hazard ratio, 0.99; 95% confidence interval [CI], 0.71 to 1.39; P = 0.01 for noninferiority; P = 0.95 for superiority). Device-related complications occurred in 31 patients in the subcutaneous ICD group and in 44 in the transvenous ICD group (hazard ratio, 0.69; 95% CI, 0.44 to 1.09); inappropriate shocks occurred in 41 and 29 patients, respectively (hazard ratio, 1.43; 95% CI, 0.89 to 2.30). Death occurred in 83 patients in the subcutaneous ICD group and in 68 in the transvenous ICD group (hazard ratio, 1.23; 95% CI, 0.89 to 1.70); appropriate shocks occurred in 83 and 57 patients, respectively (hazard ratio, 1.52; 95% CI, 1.08 to 2.12). CONCLUSIONS: In patients with an indication for an ICD but no indication for pacing, the subcutaneous ICD was noninferior to the transvenous ICD with respect to device-related complications and inappropriate shocks. (Funded by Boston Scientific; PRAETORIAN ClinicalTrials.gov number, NCT01296022.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1915932

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 483

Metadata

Authors
Knops, R. E., Olde Nordkamp, L. R. A., Delnoy, P.-P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., Mittal, S., Quast, A.-F. B. E., Smeding, L., van der Stuijt, W., de Weger, A., de Wilde, K. C., Bijsterveld, N. R., Richter, S., Brouwer, M. A., de Groot, J. R., Kooiman, K. M., Lambiase, P. D., Neuzil, P., Vernooy, K., Alings, M., Betts, T. R., Bracke, F. A. L. E., Burke, M. C., de Jong, J. S. S. G., Wright, D. J., Tijssen, J. G. P., & Wilde, A. A. M.
Venue
New England Journal of Medicine
Published
2020-08-06
Volume
383
Issue
6
Pages
526-536
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3047593651
Cited by
483
References
20
FWCI
39.10
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subcutaneous or Transvenous Defibrillator Therapy. https://app.cochat.ai/papers/10.1056/nejmoa1915932
The paper
Knops, R. E., Olde Nordkamp, L. R. A., Delnoy, P.-P. H. M., Boersma, L. V. A., Kuschyk, J., El-Chami, M. F., Bonnemeier, H., Behr, E. R., Brouwer, T. F., Kääb, S., Mittal, S., Quast, A.-F. B. E., Smeding, L., van der Stuijt, W., de Weger, A., de Wilde, K. C., Bijsterveld, N. R., Richter, S., Brouwer, M. A., . . . Wilde, A. A. M. (2020). Subcutaneous or Transvenous Defibrillator Therapy. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1915932

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.